サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1404770

体外受精（IVF）の市場規模、シェア、動向分析レポート：機器別、施術タイプ別、最終用途別、地域別、およびセグメント予測、2024年～2030年

In Vitro Fertilization Market Size, Share & Trends Analysis Report By Instrument (Disposable Devices, Culture Media), By Procedure Type (Fresh Nondonor, Frozen Nondonor), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
体外受精（IVF）の市場規模、シェア、動向分析レポート：機器別、施術タイプ別、最終用途別、地域別、およびセグメント予測、2024年～2030年
出版日: 2023年11月27日
発行: Grand View Research
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

体外受精（IVF）市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、体外受精（IVF）の世界市場規模は、2024年から2030年までのCAGRが5.54%で、2030年までに374億米ドルに達すると予測されています。

市場の成長は、市場プレイヤーの継続的な努力、ライフスタイルの変化による不妊症の発生率の増加、償還政策を改善するための政府のイニシアチブに起因しています。不妊治療のための卵細胞質内精子注入法（ICSI）などの不妊治療法の拡大は、市場成長にプラスの影響を与えると予想されます。

体外受精（IVF）（IVF）中の遺伝子異常の移行を予防できるゲノム検査施設の利用可能性は、IVF市場を牽引すると予想されます。体外受精（IVF）治療件数の増加により、保険会社は体外受精（IVF）治療に対する保険金を提供しています。例えば、2023年5月、パシフィック・ブルークロスは、不妊治療薬、不妊治療、養子縁組の補償を含む家族計画給付を組み込んだ、ヘルス＆デンタルプランである拡張パーソナル・ヘルス保険を導入しました。この機能強化により、パシフィック・ブルークロスは、カナダで初めて、そして唯一、個人向けヘルス＆デンタルプランの一部として家族計画給付を提供する保険会社となった。これにより、競合他社に負けない価格設定となり、体外受精（IVF）の治療費も抑えられました。体外受精（IVF）は、治療の自動化と標準化が進み、市場を牽引しています。

合計特殊出生率（TFR）の低下は、社会の行動シフトなどの要因に起因します。これらの要因には、農村社会から都市社会へのシフト、初回妊娠年齢の上昇、結婚の延期、雇用の増加、婚姻率の低下などが含まれます。2020年3月、米国生殖医学会とカナダ不妊・アンドロロジー学会により、米国とカナダでの対面不妊治療がCOVID-19により中断されました。しかし、COVID-19の規制緩和により多くの国で治療が再開されています。2022年1月にObstetrics &Gynecology誌が発表した調査結果では、COVID-19ワクチンは体外受精（IVF）の結果に害を及ぼさないと報告されています。これは、ワクチン接種対象者の体外受精（IVF）の普及を証明するものと期待されます。

体外受精（IVF）市場レポートハイライト：

  • 手技の種類別では、凍結ノンドナー手技による体外受精（IVF）のサイクル数が他の手技に比べて増加していることから、2023年には凍結ノンドナー手技による体外受精（IVF）の需要が増加し、凍結ノンドナー手技による体外受精（IVF）が市場を独占しました。
  • 最終用途別では、ART治療に対する需要の高まりに加え、費用対効果、専門医の利用可能性、卵子・精子バンクとの良好な関係、院内感染の可能性の最小化または皆無化が市場の成長を牽引していることから、不妊治療クリニック市場が2023年の市場を独占しました。
  • 機器別では、培養液セグメントが2023年に最大の売上シェアを占めました。これは、培養液の効率を向上させるために実施される研究活動の数が増加していることに加え、卵子・精子凍結の従業員に対する政府資金や組織的支援が増加しているためです。
  • 欧州が2023年に最大の市場シェアを占めたのは、診療所によるタイムラプス顕微鏡などの先端技術の採用が進んでいること、手頃な料金で治療が受けられること、医療基準が遵守されていることによる。
  • アジア太平洋地域は、不妊治療の需要が高く、体外受精（IVF）を支援する政策やイニシアティブが実施されているため、体外受精（IVF）の需要が増加すると予想されます。日本では、資格のあるカップルは、1サイクルにつき1,920米ドルで、最大3サイクルの自己資金を申請することができます。
  • アジア太平洋の新興諸国は、同地域での治療導入を促進するための法改正に取り組んでいます。例えば、2020年2月、インド政府は、体外受精（IVF）、人工授精、代理出産を含む生殖補助医療サービスを提供するクリニックを規制する法案を承認しました。
  • 2021年6月には、フランスの下院が、独身女性とレズビアン・カップルに生殖補助医療へのアクセスを認める法律を正式に可決しました。この画期的な法律は、これらの個人やカップルが体外受精（IVF）を含む不妊治療を無料で受けられるようにするもので、重要なマイルストーンとなります。
  • 2023年6月、インド第2位の不妊治療チェーンであるノヴァIVFファーティリティ社は、有機的拡大と買収により、今後4年間で100センターを達成する予定であると発表しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
  • 市場セグメンテーション
  • ユーザー視点の分析
    • 消費者行動分析
    • 市場影響力分析
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 業界分析ツール
    • ポーターのファイブフォース分析
    • PESTLE分析
    • 定性分析：COVID-19症が体外受精（IVF）市場に与える影響

第4章 体外受精（IVF）市場：施術タイプ分析

  • 体外受精（IVF）の施術タイプ別市場シェア分析、2023年および2030年
  • セグメントダッシュボード
  • 施術タイプの市場規模と予測および動向分析、2018年から2030年まで
    • 新鮮非ドナー
    • 凍結非ドナー
    • 新鮮ドナー
    • 凍結ドナー

第5章 体外受精（IVF）市場：最終用途分析

  • 体外受精（IVF）の最終用途市場シェア分析、2023年および2030年
  • セグメントダッシュボード
  • 最終用途の市場規模、予測および動向分析、2018～2030年
    • 不妊クリニック
    • 病院およびその他の環境

第6章 体外受精（IVF）市場：機器分析

  • 体外受精（IVF）（IVF）市場シェア分析、2023年および2030年
  • セグメントダッシュボード
  • 世界の体外受精（IVF）市場、機器別、2023年から2030年
  • 機器の市場規模、予測、動向分析、2018年から2030年まで
    • 培養培地
    • 使い捨てデバイス
    • 資本設備

第7章 地域の展望

  • 地域別の体外受精（IVF）市場：主要マーケットプレースの要点
  • 不妊治療クリニックのリスト
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東とアフリカ

第8章 競合分析

  • 企業プロファイル
    • OvaScience, Inc.
    • Vitrolife AB（publ）
    • Emd Serono, Inc.
    • FUJIFILM Irvine Scientific
    • The Cooper Companies, Inc.
    • Thermo Fisher Scientific, Inc.
    • Bayer AG
    • Merck &Co., Inc.
    • Cook Medical LLC（Cook Group）
    • Genea Biomedx
    • Progyny, Inc.
    • Boston IVF
    • Ferring Pharmaceutical BV
  • 企業の分類
  • 企業の市況分析
  • 戦略マッピング

第9章 推奨事項/主要な市場洞察

図表

List of Tables

  • Table 1. List Of Secondary Sources
  • Table 2. List Of Abbreviations
  • Table 3. Clinical Trial Analysis
  • Table 4. Comparison Between the Fresh and Frozen Donor Treatment (U.S.)
  • Table 5. Canadian Law On ART
  • Table 6. Status Of Public Funding for IVF in Canada
  • Table 7. Global In-Vitro Fertilization Market, by Region, 2018 - 2030 (USD Million)
  • Table 8. Global In-Vitro Fertilization Market, by Type, 2018 - 2030 (USD Million)
  • Table 9. Global In-Vitro Fertilization Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 10. Global In-Vitro Fertilization Instruments Market, by Region, 2018 - 2030 (USD Million)
  • Table 11. Global In-Vitro Fertilization Instruments Market, by Type, 2018 - 2030 (USD Million)
  • Table 12. North America In Vitro Fertilization, by Country, 2018 - 2030 (USD Million)
  • Table 13. North America In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 14. North America In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 15. North America In-vitro Fertilization (IVF) Instrument Market, by Country, 2018 - 2030 (USD Million)
  • Table 16. North America In-vitro Fertilization (IVF) Instrument Market, by Type, 2018 - 2030 (USD Million)
  • Table 17. U.S. In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 18. U.S. In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 19. U.S. In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 20. Canada In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 21. Canada In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 22. Canada In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 23. Europe In-vitro Fertilization (IVF) Market, by Country, 2018 - 2030 (USD Million)
  • Table 24. Europe In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 25. Europe In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 26. Europe In-vitro Fertilization (IVF) Instrument Market, by Country, 2018 - 2030 (USD Million)
  • Table 27. Europe In-vitro Fertilization (IVF) Instrument Market, by Type, 2018 - 2030 (USD Million)
  • Table 28. France In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 29. France In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 30. France In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 31. Germany In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 32. Germany In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 33. Germany In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 34. Italy In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 35. Italy In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 36. Italy In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 37. Spain In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 38. Spain In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 39. Spain In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 40. UK In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 41. UK In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 42. UK In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 43. Belgium In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 44. Belgium In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 45. Belgium In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 46. Netherlands In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 47. Netherlands In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 48. Netherlands In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 49. Switzerland In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 50. Switzerland In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 51. Switzerland In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 52. Asia Pacific In-vitro Fertilization (IVF) Market, by Country, 2018 - 2030 (USD Million)
  • Table 53. Asia Pacific In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 54. Asia Pacific In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 55. Asia Pacific In-vitro Fertilization (IVF) Instrument Market, by Country, 2018 - 2030 (USD Million)
  • Table 56. Asia Pacific In-vitro Fertilization (IVF) Instrument Market, by Type, 2018 - 2030 (USD Million)
  • Table 57. Japan In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 58. Japan In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 59. Japan In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 60. China In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 61. China In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 62. China In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 63. India In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 64. India In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 65. India In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 66. Australia In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 67. Australia In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 68. Australia In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 69. South Korea In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 70. South Korea In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 71. South Korea In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 72. Latin America In-vitro Fertilization (IVF) Market, by Country, 2018 - 2030 (USD Million)
  • Table 73. Latin America In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 74. Latin America In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 75. Latin America In-vitro Fertilization (IVF) Instrument Market, by Country, 2018 - 2030 (USD Million)
  • Table 76. Latin America In-vitro Fertilization (IVF) Instrument Market, by Type, 2018 - 2030 (USD Million)
  • Table 77. Brazil In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 78. Brazil In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 79. Brazil In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 80. Mexico In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 81. Mexico In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 82. Mexico In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 83. Argentina In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 84. Argentina In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 85. Argentina In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 86. MEA In-vitro Fertilization (IVF) Market, by Country, 2018 - 2030 (USD Million)
  • Table 87. MEA In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 88. MEA In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 89. MEA In-vitro Fertilization (IVF) Instrument Market, by Country, 2018 - 2030 (USD Million)
  • Table 90. MEA In-vitro Fertilization (IVF) Instrument Market, by Type, 2018 - 2030 (USD Million)
  • Table 91. South Africa In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 92. South Africa In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 93. South Africa In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 94. Saudi Arabia In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 95. Saudi Arabia In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 96. Saudi Arabia In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 97. UAE In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 98. UAE In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 99. UAE In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 In vitro fertilization market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Supply-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment outlook
  • Fig. 11 Segment outlook
  • Fig. 12 Competitive scenario
  • Fig. 13 In Vitro Fertilization (IVF) parent market outlook
  • Fig. 14 Penetration & growth prospect mapping
  • Fig. 15 Market dynamics
  • Fig. 16 Market driver relevance analysis (Current & future impact)
  • Fig. 17 Market restraint relevance analysis (Current & future impact)
  • Fig. 18 In vitro fertilization (IVF) market: Porter's five forces analysis
  • Fig. 19 In vitro fertilization (IVF) market: PESTLE analysis
  • Fig. 20 IVF type market: Segment dashboard
  • Fig. 21 IVF market by type: Market share analysis, 2023 & 2030
  • Fig. 22 Global In Vitro Fertilization (IVF) procedures market, by type, 2018 - 2030 (USD Million)
  • Fig. 23 Fresh nondonor market, 2018 - 2030 (USD Million)
  • Fig. 24 Frozen nondonor market 2018 - 2030 (USD Million)
  • Fig. 25 Fresh donor market 2018 - 2030 (USD Million)
  • Fig. 26 Frozen donor market 2018 - 2030 (USD Million)
  • Fig. 27 IVF End-Use market: Segment dashboard
  • Fig. 28 IVF market by End-Use: Market share analysis, 2023 & 2030
  • Fig. 29 Fertility clinics market, 2018 - 2030 (USD Million)
  • Fig. 30 Hospitals and other settings market 2018 - 2030 (USD Million)
  • Fig. 31 IVF instrument market: Segment dashboard
  • Fig. 32 IVF market by instrument: Market share analysis, 2023 & 2030
  • Fig. 33 Global In Vitro Fertilization (IVF) procedures market, by instrument, 2018 - 2030 (USD Million)
  • Fig. 34 Culture media market, 2018 - 2030 (USD Million)
  • Fig. 35 Disposable devices market, 2018 - 2030 (USD Million)
  • Fig. 36 Capital equipment market, 2018 - 2030 (USD Million)
  • Fig. 37 IVF market revenue, by region
  • Fig. 38 Regional key marketplace takeaway
  • Fig. 39 Regional key marketplace takeaway
  • Fig. 40 North America IVF market, 2018 - 2030 (USD Million)
  • Fig. 41 North America IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. estimated fertility rate, 2018 - 2030 (%)
  • Fig. 43 U.S. IVF market, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 45 Canada estimated fertility rate, 2018 - 2030 (%)
  • Fig. 46 Canada IVF market, 2018 - 2030 (USD Million)
  • Fig. 47 Canada IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 48 Europe IVF market, 2018 - 2030 (USD Million)
  • Fig. 49 Europe IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 50 France estimated fertility rate, 2018 - 2030 (%)
  • Fig. 51 France IVF market, 2018 - 2030 (USD Million)
  • Fig. 52 France IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 53 Germany estimated fertility rate, 2018 - 2030 (%)
  • Fig. 54 Germany IVF market, 2018 - 2030 (USD Million)
  • Fig. 55 Germany IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 56 Italy estimated fertility rate, 2018 - 2030 (%)
  • Fig. 57 Italy IVF market, 2018 - 2030 (USD Million)
  • Fig. 58 Italy IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 59 Spain estimated fertility rate, 2018 - 2030 (%)
  • Fig. 60 Spain IVF market, 2018 - 2030 (USD Million)
  • Fig. 61 Spain IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 62 UK estimated fertility rate, 2018 - 2030 (%)
  • Fig. 63 UK IVF market, 2018 - 2030 (USD Million)
  • Fig. 64 UK IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 65 Belgium estimated fertility rate, 2018 - 2030 (%)
  • Fig. 66 Belgium IVF market, 2018 - 2030 (USD Million)
  • Fig. 67 Belgium IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 68 Netherlands estimated fertility rate, 2018 - 2030 (%)
  • Fig. 69 Netherlands IVF market, 2018 - 2030 (USD Million)
  • Fig. 70 Netherlands IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 71 Switzerland estimated fertility rate, 2018 - 2030 (%)
  • Fig. 72 Switzerland IVF market, 2018 - 2030 (USD Million)
  • Fig. 73 Switzerland IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 74 Asia Pacific IVF market, 2018 - 2030 (USD Million)
  • Fig. 75 Asia Pacific IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 76 Japan estimated fertility rate, 2018 - 2030 (%)
  • Fig. 77 Japan IVF market, 2018 - 2030 (USD Million)
  • Fig. 78 Japan IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 79 China estimated fertility rate, 2018 - 2030 (%)
  • Fig. 80 China IVF market, 2018 - 2030 (USD Million)
  • Fig. 81 China IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 82 India. estimated fertility rate, 2018 - 2030 (%)
  • Fig. 83 India IVF market, 2018 - 2030 (USD Million)
  • Fig. 84 India IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 85 Australia estimated fertility rate, 2018 - 2030 (%)
  • Fig. 86 Australia IVF market, 2018 - 2030 (USD Million)
  • Fig. 87 Australia IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 88 South Korea estimated fertility rate, 2018 - 2030 (%)
  • Fig. 89 South Korea IVF market, 2018 - 2030 (USD Million)
  • Fig. 90 South Korea IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 91 Latin America IVF market, 2018 - 2030 (USD Million)
  • Fig. 92 Latin America IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 93 Brazil estimated fertility rate, 2018 - 2030 (%)
  • Fig. 94 Brazil IVF market, 2018 - 2030 (USD Million)
  • Fig. 95 Brazil IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 96 Mexico estimated fertility rate, 2018 - 2030 (%)
  • Fig. 97 Mexico IVF market, 2018 - 2030 (USD Million)
  • Fig. 98 Mexico IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 99 Argentina estimated fertility rate, 2018 - 2030 (%)
  • Fig. 100 Argentina IVF market, 2018 - 2030 (USD Million)
  • Fig. 101 Argentina IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 102 MEA IVF market, 2018 - 2030 (USD Million)
  • Fig. 103 MEA IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 104 South Africa estimated fertility rate, 2018 - 2030 (%)
  • Fig. 105 South Africa IVF market, 2018 - 2030 (USD Million)
  • Fig. 106 South Africa IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 107 Saudi Arabia estimated fertility rate, 2018 - 2030 (%)
  • Fig. 108 Saudi Arabia IVF market, 2018 - 2030 (USD Million)
  • Fig. 109 Saudi Arabia IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 110 UAE estimated fertility rate, 2018 - 2030 (%)
  • Fig. 111 UAE IVF market, 2018 - 2030 (USD Million)
  • Fig. 112 UAE IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 113 Company categorization
  • Fig. 114 Company market position analysis
  • Fig. 115 Strategy mapping
目次
Product Code: 978-1-68038-823-7

In Vitro Fertilization Market Growth & Trends:

The global in vitro fertilization market size is expected to reach USD 37.4 billion by 2030, with a CAGR of 5.54% from 2024 to 2030, based on a new report by Grand View Research, Inc.The market's growth can be attributed to the continuous efforts of the market players, an increase in the incidence of infertility due to lifestyle changes, and government initiatives to improve reimbursement policies. Expansion of fertility procedures, such as Intracytoplasmic sperm injection (ICSI) for treating infertility, is expected to have a positive impact on market growth.

The availability of genomic testing facilities that enable the prevention of the transfer of genetic disorders during in vitro fertilization (IVF) is expected to drive the IVF market. The insurance providers are providing coverage for IVF procedures owing to an increase in the number of IVF treatments. For instance, in May 2023, Pacific Blue Cross introduced an enhanced Personal Health Insurance, a health & dental plan, which incorporates family planning benefits, including coverage for fertility drugs, fertility treatments, and adoption. With this enhancement, Pacific Blue Cross became the first and only provider in Canada to offer family planning benefits as part of an individual health & dental plan. This led to competitive pricing and moderated IVF treatment costs. This procedure has been a successfully practiced technology, driving the market with more treatment automation and standardization.

A decline in the Total Fertility Rate (TFR) results from factors, such as behavioral shifts in society. These factors include a shift from rural to urban societies, increased age of the first pregnancy, postponement of marriage, increased employment, and lower marriage rates. In March 2020, in-person fertility treatments in the U.S. and Canada were suspended due to COVID-19 by the American Society of Reproductive Medicine and Canadian Fertility and Andrology Society. However, treatment is resumed in many countries with the ease of COVID-19 restrictions. The research findings published by the Obstetrics & Gynecology journal in January 2022 reported that COVID-19 vaccines wouldn't harm IVF outcomes. This is expected to prove the uptake of IVF in eligible vaccinated individuals.

In Vitro Fertilization Market Report Highlights:

  • Based on procedure type, the frozen nondonor type segment dominated the market in 2023 owing to the growing demand for the number of IVF cycles with the aid of frozen nondonor procedures increasing as compared to other procedures
  • Based on end-use, the fertility clinics segment dominated the market in 2023 owing to the rise in demand for ART treatments along with cost-effectiveness, availability of specialists, good relations with the egg & sperm banks, and minimal or no chances of hospital-acquired infections to drive the growth of the market
  • Based on instrument, the culture media segment held the largest revenue share in 2023 owing to a rise in the number of research activities being undertaken to improve the efficiency of culture media along with an increase in government funding and organizational support for employees for egg/sperm freezing
  • Europe held the largest market share in 2023 due to the growing adoption of advanced technologies, such as time-lapse microscopy by the clinics, availability of affordable treatment, and adherence to medical standards
  • Asia Pacific is expected to witness increased demand for IVF owing to high demand for fertility treatments and implemented policies & initiatives to support IVF. In Japan, eligible couples can apply for co-funding for a maximum of three cycles with USD 1,920 for each cycle
  • The developing countries in the Asia Pacific are undertaking legal reforms to promote treatment adoption in the region. For instance, in February 2020, the Government of India approved a bill to regulate clinics offering reproduction assistance services, including IVF, artificial insemination, and surrogacy
  • In June 2021, the lower house of parliament in France officially passed a law granting single women and lesbian couples access to medically assisted reproduction. This groundbreaking law marks a significant milestone, allowing these individuals and couples to receive fertility treatments, including IVF, at no cost
  • In June 2023, Nova IVF Fertility, India's second-largest infertility treatment chain, announced that they plan to reach 100 centers in the next four years through organic expansion and acquisitions

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation
    • 1.1.1. Procedure Type
    • 1.1.2. End-use
    • 1.1.3. Instrument
    • 1.1.4. Region
  • 1.2. Estimates and Forecast Timeline
  • 1.3. Research Methodology
    • 1.3.1. Information procurement
    • 1.3.2. Purchased Database
    • 1.3.3. GVR's Internal Database
    • 1.3.4. Secondary Sources
    • 1.3.5. Primary Research
    • 1.3.6. Details of Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Validation
    • 1.5.1. Volume Price Analysis
  • 1.6. List of Secondary Sources
  • 1.7. List of Abbreviations
  • 1.8. Research Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
    • 2.2.1. Procedure Type
    • 2.2.2. End-use
    • 2.2.3. Instrument
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Segmentation
  • 3.3. User Perspective Analysis
    • 3.3.1. Consumer Behavior Analysis
    • 3.3.2. Market Influencer Analysis
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
    • 3.4.2. Market Restraint Analysis
  • 3.5. Industry Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. PESTLE Analysis
    • 3.5.3. Qualitative Analysis: Impact of COVID-19 on IVF Market

Chapter 4. In Vitro Fertilization Market: Procedure Type Analysis

  • 4.1. In Vitro Fertilization by Procedure Type Market Share Analysis, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global In Vitro Fertilization Procedures Market, by Type, 2018 - 2030
  • 4.4. Market Size and Forecasts and Trend Analysis, 2018 - 2030 for the Procedure Type
    • 4.4.1. Fresh Nondonor
      • 4.4.1.1. Fresh nondonor market, 2018 - 2030 (USD Million)
    • 4.4.2. Frozen Nondonor
      • 4.4.2.1. Frozen nondonor market, 2018 - 2030 (USD Million)
    • 4.4.3. Fresh Donor
      • 4.4.3.1. Fresh donor market, 2018 - 2030 (USD Million)
    • 4.4.4. Frozen Donor
      • 4.4.4.1. Frozen donor market, 2018 - 2030 (USD Million)

Chapter 5. In Vitro Fertilization Market: End-use Analysis

  • 5.1. In Vitro Fertilization End-use Market Share Analysis, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Market Size and Forecasts and Trend Analysis, 2018 - 2030 for the following End-use
    • 5.3.1. Fertility Clinics
      • 5.3.1.1. Fertility clinics market, 2018 - 2030 (USD Million)
    • 5.3.2. Hospitals and Other Settings
      • 5.3.2.1. Hospitals and other settings market, 2018 - 2030 (USD Million)

Chapter 6. In Vitro Fertilization Market: Instrument Analysis

  • 6.1. In Vitro Fertilization (IVF) Market Share Analysis, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global IVF Market, by Instrument, 2023 to 2030
  • 6.4. Market Size & Forecasts and Trend Analysis, 2018 to 2030 for the Instrument
    • 6.4.1. Culture Media
      • 6.4.1.1. Culture media market, 2018 - 2030 (USD Million)
    • 6.4.2. Disposable Devices
      • 6.4.2.1. Disposable devices market, 2018 - 2030 (USD Million)
    • 6.4.3. Capital Equipment
      • 6.4.3.1. Capital equipment market, 2018 - 2030 (USD Million)

Chapter 7. Regional Outlook

  • 7.1. IVF Market by Region: Key Marketplace Takeaway
  • 7.2. List of Few Fertility Clinics
    • 7.2.1. North America
    • 7.2.2. Europe
    • 7.2.3. Asia Pacific
    • 7.2.4. Latin America
    • 7.2.5. MEA
  • 7.3. North America
    • 7.3.1. North America IVF market, 2018 - 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. U.S. estimated fertility rate, 2018 - 2030 (%)
      • 7.3.2.2. Regulatory framework
      • 7.3.2.3. Reimbursement scenario
      • 7.3.2.4. U.S. IVF market, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Canada estimated fertility rate, 2018 - 2030 (%)
      • 7.3.3.2. Regulatory framework
      • 7.3.3.3. Reimbursement scenario
      • 7.3.3.4. Canada IVF market, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe IVF market, 2018 - 2030 (USD Million)
    • 7.4.2. France
      • 7.4.2.1. France estimated fertility rate, 2018 - 2030 (%)
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Reimbursement scenario
      • 7.4.2.4. France IVF market, 2018 - 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Germany estimated fertility rate, 2018 - 2030 (%)
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Reimbursement Scenario
      • 7.4.3.4. Germany IVF market, 2018 - 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Italy estimated fertility rate, 2018 - 2030 (%)
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Reimbursement scenario
      • 7.4.4.4. Italy IVF market, 2018 - 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Spain estimated fertility rate, 2018 - 2030 (%)
      • 7.4.5.2. Regulatory framework
      • 7.4.5.3. Reimbursement scenario
      • 7.4.5.4. Spain IVF market, 2018 - 2030 (USD Million)
    • 7.4.6. UK
      • 7.4.6.1. UK estimated fertility rate, 2018 - 2030 (%)
      • 7.4.6.2. Regulatory framework
      • 7.4.6.3. Reimbursement scenario
      • 7.4.6.4. UK IVF market, 2018 - 2030 (USD Million)
    • 7.4.7. Belgium
      • 7.4.7.1. Belgium estimated fertility rate, 2018 - 2030 (%)
      • 7.4.7.2. Regulatory framework
      • 7.4.7.3. Reimbursement scenario
      • 7.4.7.4. Belgium IVF market, 2018 - 2030 (USD Million)
    • 7.4.8. Netherlands
      • 7.4.8.1. Netherlands estimated fertility rate, 2018 - 2030 (%)
      • 7.4.8.2. Regulatory framework
      • 7.4.8.3. Reimbursement scenario
      • 7.4.8.4. Netherlands IVF market, 2018 - 2030 (USD Million)
    • 7.4.9. Switzerland
      • 7.4.9.1. Switzerland estimated fertility rate, 2018 - 2030 (%)
      • 7.4.9.2. Regulatory framework
      • 7.4.9.3. Reimbursement scenario
      • 7.4.9.4. Switzerland IVF market, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific IVF market, 2018 - 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Japan estimated fertility rate, 2018 - 2030 (%)
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Rembursement scenario
      • 7.5.2.4. Japan IVF market, 2018 - 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. China estimated fertility rate, 2018 - 2030 (%)
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Reimbursement scenario
      • 7.5.3.4. China IVF market, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. India estimated fertility rate, 2018 - 2030 (%)
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Reimbursement scenario
      • 7.5.4.4. India IVF market, 2018 - 2030 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Australia estimated fertility rate, 2018 - 2030 (%)
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Reimbursement scenario
      • 7.5.5.4. Australia IVF market, 2018 - 2030 (USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. South Korea estimated fertility rate, 2018 - 2030 (%)
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Reimbursement scenario
      • 7.5.6.4. South Korea IVF market, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America IVF market, 2018 - 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Brazil estimated fertility rate, 2018 - 2030 (%)
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Reimbursement scenario
      • 7.6.2.4. Brazil IVF market, 2018 - 2030 (USD Million)
    • 7.6.3. Mexico
      • 7.6.3.1. Mexico estimated fertility rate, 2018 - 2030 (%)
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Reimbursement scenario
      • 7.6.3.4. Mexico IVF market, 2018 - 2030 (USD Million)
    • 7.6.4. Argentina
      • 7.6.4.1. Argentina estimated fertility rate, 2018 - 2030 (%)
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Reimbursement scenario
      • 7.6.4.4. Argentina IVF market, 2018 - 2030 (USD Million)
  • 7.7. Middle East & Africa
    • 7.7.1. MEA IVF market, 2018 - 2030 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. South Africa estimated fertility rate, 2018 - 2030 (%)
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Reimbursement scenario
      • 7.7.2.4. South Africa IVF market, 2018 - 2030 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Saudi Arabia estimated fertility rate, 2018 - 2030 (%)
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Reimbursement scenario
      • 7.7.3.4. Saudi Arabia IVF market, 2018 - 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. UAE estimated fertility rate, 2018 - 2030 (%)
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Reimbursement scenario
      • 7.7.4.4. UAE IVF market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Analysis

  • 8.1. Company Profiles
    • 8.1.1. OvaScience, Inc.
      • 8.1.1.1. Overview
      • 8.1.1.2. Financial Performance
      • 8.1.1.3. Service Benchmarking
      • 8.1.1.4. Strategic Initiatives
    • 8.1.2. Vitrolife AB (publ)
      • 8.1.2.1. Overview
      • 8.1.2.2. Financial Performance
      • 8.1.2.3. Service Benchmarking
      • 8.1.2.4. Strategic Initiatives
    • 8.1.3. Emd Serono, Inc.
      • 8.1.3.1. Overview
      • 8.1.3.2. Financial Performance
      • 8.1.3.3. Service Benchmarking
      • 8.1.3.4. Strategic Initiatives
    • 8.1.4. FUJIFILM Irvine Scientific
      • 8.1.4.1. Overview
      • 8.1.4.2. Financial Performance
      • 8.1.4.3. Service Benchmarking
      • 8.1.4.4. Strategic Initiatives
    • 8.1.5. The Cooper Companies, Inc.
      • 8.1.5.1. Overview
      • 8.1.5.2. Financial Performance
      • 8.1.5.3. Service Benchmarking
      • 8.1.5.4. Strategic Initiatives
    • 8.1.6. Thermo Fisher Scientific, Inc.
      • 8.1.6.1. Overview
      • 8.1.6.2. Financial Performance
      • 8.1.6.3. Service Benchmarking
      • 8.1.6.4. Strategic Initiatives
    • 8.1.7. Bayer AG
      • 8.1.7.1. Overview
      • 8.1.7.2. Financial Performance
      • 8.1.7.3. Service Benchmarking
      • 8.1.7.4. Strategic Initiatives
    • 8.1.8. Merck & Co., Inc.
      • 8.1.8.1. Overview
      • 8.1.8.2. Financial Performance
      • 8.1.8.3. Service Benchmarking
      • 8.1.8.4. Strategic Initiatives
    • 8.1.9. Cook Medical LLC (Cook Group)
      • 8.1.9.1. Overview
      • 8.1.9.2. Financial Performance
      • 8.1.9.3. Service Benchmarking
      • 8.1.9.4. Strategic Initiatives
    • 8.1.10. Genea Biomedx
      • 8.1.10.1. Overview
      • 8.1.10.2. Financial Performance
      • 8.1.10.3. Service Benchmarking
      • 8.1.10.4. Strategic Initiatives
    • 8.1.11. Progyny, Inc.
      • 8.1.11.1. Overview
      • 8.1.11.2. Financial Performance
      • 8.1.11.3. Service Benchmarking
      • 8.1.11.4. Strategic Initiatives
    • 8.1.12. Boston IVF
      • 8.1.12.1. Overview
      • 8.1.12.2. Financial Performance
      • 8.1.12.3. Service Benchmarking
      • 8.1.12.4. Strategic Initiatives
    • 8.1.13. Ferring Pharmaceutical B.V.
      • 8.1.13.1. Overview
      • 8.1.13.2. Financial Performance
      • 8.1.13.3. Service Benchmarking
      • 8.1.13.4. Strategic Initiatives
  • 8.2. Company Categorization
  • 8.3. Company Market Position Analysis
  • 8.4. Strategy Mapping

Chapter 9. Recommendations/Key Market Insights